PRX Financial Facts

Net income (loss): -0.79
Income (loss) from continuing operations: -0.79
See Full Income Statement

Accrued expenses and other current liabilities: 18.81M
Goodwill: 313.34M
See Full Balance Sheet

Earnings History for Par Pharmaceutical Companies Inc. (PRX)

  |   Expand Research on PRX
Next EPS Date 10/31/12 *Est. EPS Growth Rate +92.9% *Last Qtr.
Average EPS % Beat Rate +15.3% Revenue Growth Rate +31.3% *Last Qtr.
Average % Move 1-Wk after EPS -2.7%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
8/2/12 Q212 $1.62$1.12 +$0.50$294.3M$291.3M N/A / N/A N/A +0.1% Details
5/8/12 Q112 $0.80$0.72 +$0.08$271.5M$230.84M N/A / N/A N/A 0% Details
2/28/12 Q411 $0.78$0.75 +$0.03$253.6M$230.31M N/A / N/A N/A +31.9% Details
11/2/11 Q311 $0.74$0.73 +$0.01$215.4M$309.97M N/A / N/A N/A +68.5% Details
8/3/11 Q211 $0.84$0.77 +$0.07$224.2M$216.47M N/A / N/A N/A +67.4% Details
5/5/11 Q111 $0.96$0.89 +$0.07$233M$227.77M N/A / N/A N/A +52.1% Details
2/24/11 Q410 $0.61$0.67 -$0.06$227M$210.69M N/A / N/A N/A +45.3% Details
11/3/10 Q310 $0.89$0.54 +$0.35N/AN/A N/A / N/A N/A +51.1% Details
Like PRX Earnings? Also take a look at MYL, WPI, SOMX, TEVA

PRX Earnings News